sesamodil has been researched along with Hypertension, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T; Takahashi, T | 2 |
2 other study(ies) available for sesamodil and Hypertension, Pulmonary
| Article | Year |
|---|---|
Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem.
Topics: Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Heart; Hypertension, Pulmonary; Male; Monocrotaline; Rats; Rats, Wistar; Thiazoles | 1996 |
Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Topics: Administration, Oral; Animals; Calcium Channel Blockers; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pulmonary Artery; Rats; Rats, Wistar; Thiazoles | 1995 |